ArriVent BioPharma, Inc. reports

Location
18 Campus Blvd., Suite 100, Newtown Square, PA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
9/10/2024, 01:25 AM
Form type Sec Links Description Filing date Reporting date
8-K Report | Data FORM 8-K Sep 9, 2024 Sep 9, 2024
10-Q Report | Data 10-Q Aug 14, 2024 Jun 30, 2024
8-K Report | Data 8-K Aug 14, 2024 Aug 14, 2024
8-K/A Report | Data 8-K/A Jul 9, 2024 May 16, 2024
8-K/A Report | Data FORM 8-K/A Jul 9, 2024 Apr 20, 2024
8-K Report | Data FORM 8-K Jun 5, 2024 Jun 4, 2024
8-K Report | Data FORM 8-K May 16, 2024 May 16, 2024
10-Q Report | Data 10-Q May 8, 2024 Mar 31, 2024
8-K Report | Data 8-K May 8, 2024 May 8, 2024
8-K Report | Data FORM 8-K Apr 22, 2024 Apr 20, 2024
10-K Report 10-K Mar 28, 2024 Dec 31, 2023
8-K Report | Data FORM 8-K Mar 28, 2024 Mar 28, 2024
SC 13G Report SCHEDULE 13G Feb 13, 2024
SC 13D Report SCHEDULE 13D Feb 5, 2024
8-K Report | Data FORM 8-K Jan 30, 2024 Jan 30, 2024